Grifols investor raises €170m in UBS-led sale
An institutional shareholder of Grifols, a Spanish pharmaceutical company, raised €168m through a sale of its stake on Thursday night as southern European equities continue to prove popular.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: